NO20041485L - Farmasoytisk formulering omfattende (R)-bicalutamid - Google Patents

Farmasoytisk formulering omfattende (R)-bicalutamid

Info

Publication number: NO20041485L
Authority: NO; Norway
Prior art keywords: bicalutamide; pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 2001-10-15

Application number

NO20041485A

Other languages

English (en)

Norwegian (no)

Inventor

Nicola Frances Bateman

Original Assignee

Astrazeneca Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-15

Filing date

2004-04-13

Publication date

2004-04-13

2004-04-13 Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd

2004-04-13 Publication of NO20041485L publication Critical patent/NO20041485L/no

Links

LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20041485A 2001-10-15 2004-04-13 Farmasoytisk formulering omfattende (R)-bicalutamid NO20041485L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0103424A SE0103424D0 (sv)	2001-10-15	2001-10-15	Pharmaceutical formulation
PCT/GB2002/004621 WO2003032950A1 (en)	2001-10-15	2002-10-11	Pharmaceutical formulation comprising (r) -bicalutamide

Publications (1)

Publication Number	Publication Date
NO20041485L true NO20041485L (no)	2004-04-13

Family

ID=20285650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041485A NO20041485L (no)	2001-10-15	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid

Country Status (19)

Country	Link
US (1)	US20060058381A1 (is)
EP (1)	EP1439823A1 (is)
JP (1)	JP3639587B2 (is)
KR (1)	KR20050035163A (is)
CN (1)	CN1571658A (is)
AR (1)	AR036877A1 (is)
BR (1)	BR0213248A (is)
CA (1)	CA2462219A1 (is)
CO (1)	CO5580755A2 (is)
HU (1)	HUP0401369A3 (is)
IL (1)	IL161306A0 (is)
IS (1)	IS7219A (is)
MX (1)	MXPA04003520A (is)
NO (1)	NO20041485L (is)
PL (1)	PL368226A1 (is)
RU (1)	RU2004115023A (is)
SE (1)	SE0103424D0 (is)
WO (1)	WO2003032950A1 (is)
ZA (1)	ZA200402729B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK10722003A3 (sk) *	2001-02-27	2004-02-03	Astrazeneca Ab	Farmaceutická formulácia obsahujúca bicalutamid v pevnej disperzii s enterickým polymérom a jej použitie
DK3366283T3 (da)	2004-01-20	2021-11-22	Novartis Ag	Direkte sammenpresningsformulering og fremgangsmåde
WO2006090129A2 (en) *	2005-02-23	2006-08-31	Astrazeneca Ab	Bicalutamide for delivering increasing steady state plasma levels
US20100047338A1 (en)	2008-03-14	2010-02-25	Angela Brodie	Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
US20080045600A1 (en) *	2006-08-17	2008-02-21	Gawande Rahul S	Bicalutamide compositions
AU2010210422A1 (en)	2009-02-05	2011-08-18	Tokai Pharmaceuticals, Inc.	Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
CN101987086B (zh) *	2009-08-03	2012-07-18	北京化工大学	一种超细比卡鲁胺口服片剂及其制备方法
JP2014523445A (ja) *	2011-07-18	2014-09-11	トーカイファーマシューティカルズ，インク．	前立腺癌を処置するための新規な組成物及び方法
EP4450130A3 (en)	2012-09-11	2025-01-08	Medivation Prostate Therapeutics LLC	Formulations of enzalutamide
KR20150127720A (ko)	2013-03-14	2015-11-17	유니버시티 오브 매릴랜드, 발티모어	안드로겐 수용체 하향 조절제 및 그의 용도
WO2015023710A1 (en)	2013-08-12	2015-02-19	Tokai Pharmaceuticals, Inc.	Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
RS66323B1 (sr) *	2014-12-05	2025-01-31	Aragon Pharmaceuticals Inc	Sastavi protiv raka
MX381829B (es)	2014-12-05	2025-03-13	Aragon Pharmaceuticals Inc	Composiciones anticancerígenas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3629237A (en) *	1968-09-12	1971-12-21	Shinetsu Chemical Co	Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
US4309405A (en) *	1979-08-09	1982-01-05	American Home Products Corporation	Sustained release pharmaceutical compositions
ATE28864T1 (de) *	1982-07-23	1987-08-15	Ici Plc	Amide-derivate.
US4946686A (en) *	1987-09-24	1990-08-07	Merck & Co., Inc.	Solubility modulated drug delivery system
EP0580860B2 (en) *	1991-04-16	2004-12-15	Nippon Shinyaku Company, Limited	Method of manufacturing solid dispersion
EP0748220A4 (en) *	1994-01-21	1997-09-10	Sepracor Inc	METHOD AND COMPOSITIONS FOR TREATING ANDROGEN-DEPENDENT DISEASES USING OPTICALLY PURE R - (-) CASODEX
SK10722003A3 (sk) *	2001-02-27	2004-02-03	Astrazeneca Ab	Farmaceutická formulácia obsahujúca bicalutamid v pevnej disperzii s enterickým polymérom a jej použitie
WO2002080902A1 (en) *	2001-04-02	2002-10-17	Astrazeneca Ab	Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp

2001
- 2001-10-15 SE SE0103424A patent/SE0103424D0/xx unknown
2002
- 2002-10-11 CN CNA028203747A patent/CN1571658A/zh active Pending
- 2002-10-11 WO PCT/GB2002/004621 patent/WO2003032950A1/en not_active Ceased
- 2002-10-11 CA CA002462219A patent/CA2462219A1/en not_active Abandoned
- 2002-10-11 PL PL02368226A patent/PL368226A1/xx not_active Application Discontinuation
- 2002-10-11 JP JP2003535754A patent/JP3639587B2/ja not_active Expired - Fee Related
- 2002-10-11 KR KR1020047005493A patent/KR20050035163A/ko not_active Withdrawn
- 2002-10-11 MX MXPA04003520A patent/MXPA04003520A/es unknown
- 2002-10-11 HU HU0401369A patent/HUP0401369A3/hu unknown
- 2002-10-11 IL IL16130602A patent/IL161306A0/xx unknown
- 2002-10-11 RU RU2004115023/15A patent/RU2004115023A/ru not_active Application Discontinuation
- 2002-10-11 BR BR0213248-6A patent/BR0213248A/pt not_active Application Discontinuation
- 2002-10-11 EP EP02770069A patent/EP1439823A1/en not_active Withdrawn
- 2002-10-11 US US10/492,629 patent/US20060058381A1/en not_active Abandoned
- 2002-10-11 AR ARP020103826A patent/AR036877A1/es unknown
2004
- 2004-04-07 ZA ZA200402729A patent/ZA200402729B/xx unknown
- 2004-04-13 NO NO20041485A patent/NO20041485L/no not_active Application Discontinuation
- 2004-04-14 IS IS7219A patent/IS7219A/is unknown
- 2004-05-12 CO CO04043957A patent/CO5580755A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003032950A1 (en)	2003-04-24
JP2004521963A (ja)	2004-07-22
HUP0401369A2 (hu)	2004-11-29
AR036877A1 (es)	2004-10-13
MXPA04003520A (es)	2004-07-23
IL161306A0 (en)	2004-09-27
ZA200402729B (en)	2005-01-13
JP3639587B2 (ja)	2005-04-20
SE0103424D0 (sv)	2001-10-15
PL368226A1 (en)	2005-03-21
US20060058381A1 (en)	2006-03-16
HUP0401369A3 (en)	2006-05-29
CO5580755A2 (es)	2005-11-30
KR20050035163A (ko)	2005-04-15
IS7219A (is)	2004-04-14
EP1439823A1 (en)	2004-07-28
CA2462219A1 (en)	2003-04-24
BR0213248A (pt)	2004-09-28
RU2004115023A (ru)	2005-04-10
CN1571658A (zh)	2005-01-26

Legal Events

Date	Code	Title	Description
2006-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
NO20033785L (no)	2003-10-24	Farmasöytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
IS7051A (is)	2003-11-26	Lyfjasamsetningar
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
EP1408896A4 (en)	2010-02-24	PHARMACEUTICAL COMPOSITION
NO20042502L (no)	2004-08-09	Farmasoytisk formulering omfattende bicalutamid
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
DK1429753T3 (da)	2007-05-14	Farmaceutisk sammensætning omfattende gamma-butyrobetain
NO20015534D0 (no)	2001-11-12	Farmasöytisk blandeapparat
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
SE0102572D0 (sv)	2001-07-19	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0101325D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0101171D0 (sv)	2001-04-02	Pharmaceutical formulation
SE0102069D0 (sv)	2001-06-21	Pharmaceutical formulation
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS